Literature DB >> 21402694

ADAMTS10 protein interacts with fibrillin-1 and promotes its deposition in extracellular matrix of cultured fibroblasts.

Wendy E Kutz1, Lauren W Wang, Hannah L Bader, Alana K Majors, Kazushi Iwata, Elias I Traboulsi, Lynn Y Sakai, Douglas R Keene, Suneel S Apte.   

Abstract

Autosomal recessive and autosomal dominant forms of Weill-Marchesani syndrome, an inherited connective tissue disorder, are caused by mutations in ADAMTS10 (encoding a secreted metalloprotease) and FBN1 (encoding fibrillin-1, which forms tissue microfibrils), respectively, yet they are clinically indistinguishable. This genetic connection prompted investigation of a potential functional relationship between ADAMTS10 and fibrillin-1. Specifically, fibrillin-1 was investigated as a potential ADAMTS10 binding partner and substrate, and the role of ADAMTS10 in influencing microfibril biogenesis was addressed. Using ligand affinity blotting and surface plasmon resonance, recombinant ADAMTS10 was found to bind to fibrillin-1 with a high degree of specificity and with high affinity. Two sites of ADAMTS10 binding to fibrillin-1 were identified, one toward the N terminus and another in the C-terminal half of fibrillin-1. Confocal microscopy and immunoelectron microscopy localized ADAMTS10 to fibrillin-1-containing microfibrils in human tissues. Furin-activated ADAMTS10 could cleave fibrillin-1, but innate resistance of ADAMTS10 zymogen to propeptide excision by furin was observed, suggesting that, unless activated, ADAMTS10 is an inefficient fibrillinase. To investigate the role of ADAMTS10 in microfibril biogenesis, fetal bovine nuchal ligament cells were cultured in the presence or absence of ADAMTS10. Exogenously added ADAMTS10 led to accelerated fibrillin-1 microfibril biogenesis. Conversely, fibroblasts obtained from a Weill-Marchesani syndrome patient with ADAMTS10 mutations deposited fibrillin-1 microfibrils sparsely compared with unaffected control cells. Taken together, these findings suggest that ADAMTS10 participates in microfibril biogenesis rather than in fibrillin-1 turnover.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402694      PMCID: PMC3089559          DOI: 10.1074/jbc.M111.231571

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome.

Authors:  Laurence Faivre; Hélène Dollfus; Stanislas Lyonnet; Yves Alembik; André Mégarbané; John Samples; Robert J Gorlin; Abdulrahman Alswaid; Josué Feingold; Martine Le Merrer; Arnold Munnich; Valérie Cormier-Daire
Journal:  Am J Med Genet A       Date:  2003-12-01       Impact factor: 2.802

Review 2.  A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family.

Authors:  Suneel S Apte
Journal:  Int J Biochem Cell Biol       Date:  2004-06       Impact factor: 5.085

Review 3.  Fibrillin microfibrils: multipurpose extracellular networks in organismal physiology.

Authors:  Francesco Ramirez; Lynn Y Sakai; Harry C Dietz; Daniel B Rifkin
Journal:  Physiol Genomics       Date:  2004-10-04       Impact factor: 3.107

Review 4.  The Marfan syndrome.

Authors:  R E Pyeritz
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

5.  An ADAMTS17 splice donor site mutation in dogs with primary lens luxation.

Authors:  Fabiana H G Farias; Gary S Johnson; Jeremy F Taylor; Elizabeth Giuliano; Martin L Katz; Douglas N Sanders; Robert D Schnabel; Stephanie D McKay; Shahnawaz Khan; Puya Gharahkhani; Caroline A O'Leary; Louise Pettitt; Oliver P Forman; Mike Boursnell; Bryan McLaughlin; Saija Ahonen; Hannes Lohi; Elena Hernandez-Merino; David J Gould; David R Sargan; Cathryn Mellersh
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

6.  Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein.

Authors:  Zenzo Isogai; Robert N Ono; Shin Ushiro; Douglas R Keene; Yan Chen; Roberta Mazzieri; Noe L Charbonneau; Dieter P Reinhardt; Daniel B Rifkin; Lynn Y Sakai
Journal:  J Biol Chem       Date:  2002-11-11       Impact factor: 5.157

7.  Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.

Authors:  Daniel P Judge; Nancy J Biery; Douglas R Keene; Jessica Geubtner; Loretha Myers; David L Huso; Lynn Y Sakai; Harry C Dietz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  ADAMTSL-3/punctin-2, a novel glycoprotein in extracellular matrix related to the ADAMTS family of metalloproteases.

Authors:  Nina G Hall; Philip Klenotic; Bela Anand-Apte; Suneel S Apte
Journal:  Matrix Biol       Date:  2003-11       Impact factor: 11.583

9.  ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome.

Authors:  Nathalie Dagoneau; Catherine Benoist-Lasselin; Céline Huber; Laurence Faivre; André Mégarbané; Abdulrahman Alswaid; Hélène Dollfus; Yves Alembik; Arnold Munnich; Laurence Legeai-Mallet; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2004-09-13       Impact factor: 11.025

10.  In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome.

Authors:  L Faivre; R J Gorlin; M K Wirtz; M Godfrey; N Dagoneau; J R Samples; M Le Merrer; G Collod-Beroud; C Boileau; A Munnich; V Cormier-Daire
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

View more
  63 in total

Review 1.  Bicuspid aortic valve aortopathy: genetics, pathophysiology and medical therapy.

Authors:  Nada Abdulkareem; Jeremy Smelt; Marjan Jahangiri
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-31

2.  Cell-Based Interaction Analysis of ADAMTS Proteases and ADAMTS-Like Proteins with Fibrillin Microfibrils.

Authors:  Dirk Hubmacher
Journal:  Methods Mol Biol       Date:  2020

3.  ADAMTSL4, a secreted glycoprotein widely distributed in the eye, binds fibrillin-1 microfibrils and accelerates microfibril biogenesis.

Authors:  Luis A R Gabriel; Lauren W Wang; Hannah Bader; Jason C Ho; Alana K Majors; Joe G Hollyfield; Elias I Traboulsi; Suneel S Apte
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-31       Impact factor: 4.799

4.  Limb- and tendon-specific Adamtsl2 deletion identifies a role for ADAMTSL2 in tendon growth in a mouse model for geleophysic dysplasia.

Authors:  Dirk Hubmacher; Nandaraj Taye; Zerina Balic; Stetson Thacker; Sheila M Adams; David E Birk; Ronen Schweitzer; Suneel S Apte
Journal:  Matrix Biol       Date:  2019-02-07       Impact factor: 11.583

Review 5.  FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.

Authors:  Lynn Y Sakai; Douglas R Keene; Marjolijn Renard; Julie De Backer
Journal:  Gene       Date:  2016-07-18       Impact factor: 3.688

6.  Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway.

Authors:  Takeshi Oichi; Yuki Taniguchi; Kazuhito Soma; Yasushi Oshima; Fumiko Yano; Yoshifumi Mori; Ryota Chijimatsu; Joo-Ri Kim-Kaneyama; Sakae Tanaka; Taku Saito
Journal:  Cell Mol Life Sci       Date:  2019-06-14       Impact factor: 9.261

7.  Human eye development is characterized by coordinated expression of fibrillin isoforms.

Authors:  Dirk Hubmacher; Dieter P Reinhardt; Thomas Plesec; Katja Schenke-Layland; Suneel S Apte
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

Review 8.  Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma.

Authors:  Janice A Vranka; Mary J Kelley; Ted S Acott; Kate E Keller
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

Review 9.  The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure.

Authors:  John Kuchtey; Rachel W Kuchtey
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-12       Impact factor: 2.671

10.  Screening ADAMTS10 in dog populations supports Gly661Arg as the glaucoma-causing variant in beagles.

Authors:  John Kuchtey; Jessica Kunkel; Douglas Esson; John S Sapienza; Daniel A Ward; Caryn E Plummer; Kirk N Gelatt; Rachel W Kuchtey
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-13       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.